Literature DB >> 27749738

Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).

Ellen B Gold1, Sybil L Crawford, Janie F Shelton, Ping G Tepper, Carolyn J Crandall, Gail A Greendale, Karen A Matthews, Rebecca C Thurston, Nancy E Avis.   

Abstract

OBJECTIVE: Greater body mass index (BMI) and body fat are associated with vasomotor symptoms (VMS). Thus, weight loss may prevent VMS. We analyzed whether concurrent BMI or waist circumference and/or changes in weight or waist circumference predicted incident VMS and whether these relations differed by menopause stage or race/ethnicity.
METHODS: Data from 10 follow-up visits for 1,546 participants in the Study of Women's Health Across the Nation who reported no VMS at baseline were modeled for time to first symptomatic visit in relation to concurrent BMI and waist circumference and change in weight and waist circumference during early and late menopause using discrete survival analyses, adjusting for covariates.
RESULTS: Greater concurrent BMI and waist circumference were significantly related to greater any and frequent (≥6 d in the last 2 wk) incident VMS in early menopause and lower VMS risk in late menopause. Percentage weight change since baseline and since the prior visit was unrelated to incident any VMS in either menopause stage. Percentage weight change since baseline had a significant shallow U-shaped association with incident frequent VMS in early menopause (P = 0.02), a shallow inverse U-shape in late menopause (P = 0.02), and a significant interaction with menopause stage (P = 0.004) but not with race/ethnicity. Recent weight change was unassociated with incident VMS in either menopause stage. Results were similar for waist change.
CONCLUSIONS: Concurrent BMI and waist circumference were positively related to incident VMS in early menopause and negatively related in late menopause. Maintaining healthy weight in early menopause may help prevent VMS.

Entities:  

Mesh:

Year:  2017        PMID: 27749738      PMCID: PMC5177513          DOI: 10.1097/GME.0000000000000723

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  31 in total

1.  "MENOPAUSAL SYMPTOMS" IN WOMEN OF VARIOUS AGES.

Authors:  B L NEUGARTEN; R J KRAINES
Journal:  Psychosom Med       Date:  1965 May-Jun       Impact factor: 4.312

2.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

3.  Duration of menopausal vasomotor symptoms over the menopause transition.

Authors:  Nancy E Avis; Sybil L Crawford; Gail Greendale; Joyce T Bromberger; Susan A Everson-Rose; Ellen B Gold; Rachel Hess; Hadine Joffe; Howard M Kravitz; Ping G Tepper; Rebecca C Thurston
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

4.  Patterns of ambulatory care use for gynecologic conditions: A national study.

Authors:  W K Nicholson; S A Ellison; H Grason; N R Powe
Journal:  Am J Obstet Gynecol       Date:  2001-03       Impact factor: 8.661

5.  Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative.

Authors:  Candyce H Kroenke; Bette J Caan; Marcia L Stefanick; Garnet Anderson; Robert Brzyski; Karen C Johnson; Erin LeBlanc; Cathy Lee; Andrea Z La Croix; Hannah Lui Park; Stacy T Sims; Mara Vitolins; Robert Wallace
Journal:  Menopause       Date:  2012-09       Impact factor: 2.953

6.  Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.

Authors:  R E Williams; L Kalilani; D Britt DiBenedetti; X Zhou; A L Granger; S E Fehnel; K B Levine; J Jordan; R V Clark
Journal:  Climacteric       Date:  2008-02       Impact factor: 3.005

7.  Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation.

Authors:  Ellen B Gold; Gladys Block; Sybil Crawford; Laurie Lachance; Gordon FitzGerald; Heidi Miracle; Sheryl Sherman
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

8.  The amplification of somatic symptoms.

Authors:  A J Barsky; J D Goodson; R S Lane; P D Cleary
Journal:  Psychosom Med       Date:  1988 Sep-Oct       Impact factor: 4.312

9.  Menopause-related symptoms: what are the background factors? A prospective population-based cohort study of Swedish women (The Women's Health in Lund Area study).

Authors:  Cairu Li; Göran Samsioe; Christer Borgfeldt; Jonas Lidfeldt; Carl David Agardh; Christina Nerbrand
Journal:  Am J Obstet Gynecol       Date:  2003-12       Impact factor: 8.661

10.  Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation.

Authors:  Rebecca C Thurston; MaryFran R Sowers; Barbara Sternfeld; Ellen B Gold; Joyce Bromberger; Yuefang Chang; Hadine Joffe; Carolyn J Crandall; L Elaine Waetjen; Karen A Matthews
Journal:  Am J Epidemiol       Date:  2009-08-12       Impact factor: 4.897

View more
  16 in total

Review 1.  Vasomotor Symptoms Across the Menopause Transition: Differences Among Women.

Authors:  Nancy E Avis; Sybil L Crawford; Robin Green
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE).

Authors:  M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi
Journal:  J Endocrinol Invest       Date:  2019-05-20       Impact factor: 4.256

3.  Menopausal hormone therapy trends before versus after 2002: impact of the Women's Health Initiative Study Results.

Authors:  Sybil L Crawford; Carolyn J Crandall; Carol A Derby; Samar R El Khoudary; L Elaine Waetjen; Mary Fischer; Hadine Joffe
Journal:  Menopause       Date:  2018-12-21       Impact factor: 2.953

Review 4.  Symptoms of menopause - global prevalence, physiology and implications.

Authors:  Patrizia Monteleone; Giulia Mascagni; Andrea Giannini; Andrea R Genazzani; Tommaso Simoncini
Journal:  Nat Rev Endocrinol       Date:  2018-02-02       Impact factor: 43.330

Review 5.  Using menopausal hormone therapy after a cancer diagnosis in Ireland.

Authors:  Fionán Donohoe; Yvonne O'Meara; Aidin Roberts; Louise Comerford; Catherine M Kelly; Janice M Walshe; Deirdre Lundy; Martha Hickey; Donal J Brennan
Journal:  Ir J Med Sci       Date:  2022-02-09       Impact factor: 1.568

6.  The longitudinal relation of inflammation to incidence of vasomotor symptoms.

Authors:  Ellen B Gold; Guibo Xing; Nancy E Avis; Sioban Harlow; Hadine Joffe; Karen Matthews; Jelena M Pavlovic; Rebecca C Thurston; Elaine Waetjen
Journal:  Menopause       Date:  2022-08-01       Impact factor: 3.310

7.  The relationships of multiple factors to menopausal symptoms in different racial/ethnic groups of midlife women: The structural equation modeling.

Authors:  Eun-Ok Im; Sun Ju Chang; Eunice Chee; Wonshik Chee
Journal:  Women Health       Date:  2018-07-24

8.  Understanding the complex relationships underlying hot flashes: a Bayesian network approach.

Authors:  Rebecca L Smith; Lisa M Gallicchio; Jodi A Flaws
Journal:  Menopause       Date:  2018-02       Impact factor: 2.953

9.  Obesity, smoking, and risk of vasomotor menopausal symptoms: a pooled analysis of eight cohort studies.

Authors:  Debra J Anderson; Hsin-Fang Chung; Charrlotte A Seib; Annette J Dobson; Diana Kuh; Eric J Brunner; Sybil L Crawford; Nancy E Avis; Ellen B Gold; Gail A Greendale; Ellen S Mitchell; Nancy F Woods; Toyoko Yoshizawa; Gita D Mishra
Journal:  Am J Obstet Gynecol       Date:  2019-11-06       Impact factor: 8.661

10.  Age at menarche and risk of vasomotor menopausal symptoms: a pooled analysis of six studies.

Authors:  H-F Chung; D Zhu; A J Dobson; D Kuh; E B Gold; S L Crawford; N E Avis; E S Mitchell; N F Woods; D J Anderson; G D Mishra
Journal:  BJOG       Date:  2020-07-21       Impact factor: 6.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.